Flavonoid allosteric modulation of mutated visual rhodopsin associated with retinitis pigmentosa

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Herrera Hernández, María Guadalupe ^a,b   Ramon, Eva ^a   Lupala, Cecylia S ^a   Tena Campos, Mercè ^a   Pérez, Juan J ^a   Garriga, Pere ^a  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b INSTITUTO NACIONAL DE INVESTIGACIONES FORESTALES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; MUTANT PROTEIN; PROTEIN BINDING; QUERCETIN; RHODOPSIN;

ALLOSTERISM; ANIMAL; BOVINE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR DYNAMICS; PATHOLOGY; PROTEIN CONFORMATION; RETINITIS PIGMENTOSA;

ALLOSTERIC REGULATION; ANIMALS; CATTLE; FLAVONOIDS; MOLECULAR DYNAMICS SIMULATION; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; QUERCETIN; RETINITIS PIGMENTOSA; RHODOPSIN;

EID: 85029385050     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-11391-x     Document Type: Article

References (51)

1. Stevens, R. C. et al. The GPCR Network: a large-scale collaboration to determine human GPCR structure and function. Nat. Rev. Drug Discov. 12, 25-34 (2013).
2. Shonberg, J., Kling, R. C., Gmeiner, P. & Löber, S. GPCR crystal structures: Medicinal chemistry in the pocket. Bioorg. Med. Chem. 23, 3880-906 (2015).
3. Zhang, D., Zhao, Q. & Wu, B. Structural Studies of G Protein-Coupled Receptors. Mol. Cells 38, 836-42 (2015).
4. Palczewski, K. et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-45 (2000).
5. Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet (London, England) 368, 1795-809 (2006).
6. Petrs-Silva, H. & Linden, R. Advances in gene therapy technologies to treat retinitis pigmentosa. Clin. Ophthalmol. 8, 127-36 (2014).
7. Guadagni, V., Novelli, E., Piano, I., Gargini, C. & Strettoi, E. Pharmacological approaches to retinitis pigmentosa: A laboratory perspective. Prog. Retin. Eye Res. 48, 62-81 (2015).
8. Bernier, V., Bichet, D. G. & Bouvier, M. Pharmacological chaperone action on G-protein-coupled receptors. Curr. Opin. Pharmacol. 4, 528-33 (2004).
9. Krebs, M. P. et al. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J. Mol. Biol. 395, 1063-78 (2010).
10. Clemson, C. M. et al. Therapeutic potential of valproic acid for retinitis pigmentosa. Br. J. Ophthalmol. 95, 89-93 (2011).
11. Koenekoop, R. K. et al. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial. Lancet (London, England) 384, 1513-20 (2014).
12. Komeima, K., Usui, S., Shen, J., Rogers, B. S. & Campochiaro, P. A. Blockade of neuronal nitric oxide synthase reduces cone cell death in a model of retinitis pigmentosa. Free Radic. Biol. Med. 45, 905-12 (2008).
13. Lee, S. Y. et al. N-Acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa. J. Cell. Physiol. 226, 1843-9 (2011).
14. D'Andrea, G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia 106, 256-71 (2015).
15. Toledo, D. et al. Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin. J. Biol. Chem. 286, 39993-40001 (2011).
16. Dong, X., Ramon, E., Herrera-Hernández, M. G. & Garriga, P. Phospholipid Bicelles Improve the Conformational Stability of Rhodopsin Mutants Associated with Retinitis Pigmentosa. Biochemistry 54, 4795-4804 (2015).
17. Palczewski, K. G protein-coupled receptor rhodopsin. Annu. Rev. Biochem. 75, 743-67 (2006).
18. Ramon, E. et al. Differential light-induced responses in sectorial inherited retinal degeneration. J. Biol. Chem. 289, 35918-28 (2014).
19. Aguilà, M. et al. Structural coupling of 11-cis-7-methyl-retinal and amino acids at the ligand binding pocket of rhodopsin. Photochem. Photobiol. 85, 485-93.
20. Liu, M. Y. et al. Thermal stability of rhodopsin and progression of retinitis pigmentosa: comparison of S186W and D190N rhodopsin mutants. J. Biol. Chem. 288, 17698-712 (2013).
21. Lamb, T. D. & Pugh, E. N. Phototransduction, dark adaptation, and rhodopsin regeneration the proctor lecture. Invest. Ophthalmol. Vis. Sci. 47, 5137-52 (2006).
22. Frederick, J. M. et al. Mutant rhodopsin transgene expression on a null background. Invest. Ophthalmol. Vis. Sci. 42, 826-33 (2001).
23. Deretic, D. et al. Rhodopsin C terminus, the site of mutations causing retinal disease, regulates trafficking by binding to ADP-ribosylation factor 4 (ARF4). Proc. Natl. Acad. Sci. USA 102, 3301-6 (2005).
24. Srinivasan, S., Ramon, E., Cordomí, A. & Garriga, P. Binding specificity of retinal analogs to photoactivated visual pigments suggest mechanism for fine-tuning GPCR-ligand interactions. Chem. Biol. 21, 369-78 (2014).
25. Farrens, D. L. & Khorana, H. G. Structure and function in rhodopsin. Measurement of the rate of metarhodopsin II decay by fluorescence spectroscopy. J. Biol. Chem. 270, 5073-6 (1995).
26. Zheng, Y. et al. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists. Nature 540, 458-461 (2016).
27. Oswald, C. et al. Intracellular allosteric antagonism of the CCR9 receptor. Nature 540, 462-465 (2016).
28. Sekharan, S. & Morokuma, K. Why 11-cis-retinal? Why not 7-cis-, 9-cis-, or 13-cis-retinal in the eye? J. Am. Chem. Soc. 133, 19052-5 (2011).
29. Maeda, T., Maeda, A., Casadesus, G., Palczewski, K. & Margaron, P. Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice. Invest. Ophthalmol. Vis. Sci. 50, 4368-78 (2009).
30. Maeda, T. et al. QLT091001, a 9-cis-retinal analog, is well-tolerated by retinas of mice with impaired visual cycles. Invest. Ophthalmol. Vis. Sci. 54, 455-66 (2013).
31. Van Hooser, J. P. et al. Recovery of visual functions in a mouse model of Leber congenital amaurosis. J. Biol. Chem. 277, 19173-82 (2002).
32. Gorostiza, P. et al. Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptor. PNAS 104, 10865-10870 (2007).
33. Bahamonde, M. I. et al. Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand. Bioconjug. Chem. 25, 1847-1854 (2014).
34. Izquierdo-Serra, M. et al. Two-photon neuronal and astrocytic stimulation with azobenzene-based photoswitches. J. Am. Chem. Soc. 136, 8693-8701 (2014).
35. Miesenböck, G. The optogenetic catechism. Science 326, 395-9 (2009).
36. Kramer, R. H., Mourot, A. & Adesnik, H. Optogenetic pharmacology for control of native neuronal signaling proteins. Nat. Neurosci. 16, 816-23 (2013).
37. Krebs, M. P., Noorwez, S. M., Malhotra, R. & Kaushal, S. Quality control of integral membrane proteins. Trends Biochem. Sci. 29, 648-55 (2004).
38. Sawkar, A. R., D'Haeze, W. & Kelly, J. W. Therapeutic strategies to ameliorate lysosomal storage disorders-a focus on Gaucher disease. Cell. Mol. Life Sci. 63, 1179-92 (2006).
39. Noorwez, S. M., Ostrov, D. A., McDowell, J. H., Krebs, M. P. & Kaushal, S. A high-throughput screening method for small-molecule pharmacologic chaperones of misfolded rhodopsin. Invest. Ophthalmol. Vis. Sci. 49, 3224-30 (2008).
40. Opefi, C. A., South, K., Reynolds, C. A., Smith, S. O. & Reeves, P. J. Retinitis pigmentosa mutants provide insight into the role of the N-terminal cap in rhodopsin folding, structure, and function. J. Biol. Chem. 288, 33912-26 (2013).
41. Kalt, W., Hanneken, A., Milbury, P. & Tremblay, F. Recent research on polyphenolics in vision and eye health. J. Agric. Food Chem. 58, 4001-7 (2010).
42. Klco, J. M., Wiegand, C. B., Narzinski, K. & Baranski, T. J. Essential role for the second extracellular loop in C5a receptor activation. Nat. Struct. Mol. Biol. 12, 320-6 (2005).
43. Scarselli, M., Li, B., Kim, S.-K. & Wess, J. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. J. Biol. Chem. 282, 7385-96 (2007).
44. Janz, J. M., Fay, J. F. & Farrens, D. L. Stability of dark state rhodopsin is mediated by a conserved ion pair in intradiscal loop E-2. J. Biol. Chem. 278, 16982-91 (2003).
45. Rader, A. J. et al. Identification of core amino acids stabilizing rhodopsin. Proc. Natl. Acad. Sci. USA 101, 7246-51 (2004).
46. Ahuja, S. et al. Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. Nat. Struct. Mol. Biol. 16, 168-75 (2009).
47. Oprian, D. D., Molday, R. S., Kaufman, R. J. & Khorana, H. G. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc. Natl. Acad. Sci. USA 84, 8874-8 (1987).
48. Park, J.H., Scheerer, P., Hofmann, K.P., Choe, H.-W., Ernst, O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183-187(2008).
49. Li, J., Edwards, P. C., Burghammer, M., Villa, C. & Schertler, G. F. X. Structure of Bovine Rhodopsin in a Trigonal Crystal Form. J. Mol. Biol. 343, 1409-1438 (2004).
50. Nakamichi, H. & Okada, T. X-ray crystallographic analysis of 9-cis-rhodopsin, a model analogue visual pigment. Photochem. Photobiol. 83, 232-5 (2007).
51. Choe, H. W. et al. Crystal structure of metarhodopsin II. Nature 471, 651-655 (2011).